Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

  1. Kong, A.
  2. Rea, D.
  3. Ahmed, S.
  4. Beck, J.T.
  5. López, R.L.
  6. Biganzoli, L.
  7. Armstrong, A.C.
  8. Aglietta, M.
  9. Alba, E.
  10. Campone, M.
  11. Schmitz, S.-F.H.
  12. Lefebvre, C.
  13. Akimov, M.
  14. Lee, S.-C.
Revista:
Oncotarget

ISSN: 1949-2553

Ano de publicación: 2016

Volume: 7

Número: 25

Páxinas: 37680-37692

Tipo: Artigo

DOI: 10.18632/ONCOTARGET.8974 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus